(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641734

細胞培養ハイドロゲルの世界市場：ハイドロゲルタイプ別、用途別、エンドユーザー別 - 機会分析と産業予測（2024年～2035年）

Cell Culture Hydrogel Market By Type of Hydrogel, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日
ページ情報
英文 321 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
細胞培養ハイドロゲルの世界市場：ハイドロゲルタイプ別、用途別、エンドユーザー別 - 機会分析と産業予測（2024年～2035年）
出版日: 2024年12月01日
発行: Allied Market Research
ページ情報: 英文 321 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の細胞培養ハイドロゲルの市場規模は、2023年には4億米ドルと評価され、2024年～2035年のCAGRは15.0％を示し、2035年には21億3,670万米ドルに達すると推定されています。

Cell Culture Hydrogel Market-IMG1

細胞培養ハイドロゲルは、試験管内で細胞を培養するための細胞外マトリックス（ECM）環境を模倣するように設計された、三次元で水分に富んだ高分子材料です。これらのハイドロゲルは、細胞機能、増殖、分化の維持に不可欠な構造的支持、生化学的手がかり、機械的特性を提供します。ハイドロゲルは、組織工学、再生医療、創薬などの生物医学研究において一般的に使用されています。

幹細胞治療と研究への注目の高まりは、ハイドロゲルの需要を煽る重要な要因であり、ハイドロゲルは天然の細胞環境を模倣することで幹細胞の成長と分化をサポートします。加えて、薬剤スクリーニング、オルガノイド開発、再生医療を目的とした2D細胞培養から3D細胞培養への移行は、ハイドロゲルの需要を著しく増大させています。機械的特性が調整可能な合成ハイドロゲルに支えられたオルガノイド培養は、従来のマトリゲル足場と比較して再現性が向上し、より正確に臓器のような構造を模倣することが研究で示されています。さらに、創薬や薬剤開発への応用が市場開拓の原動力となっています。これは、ハイドロゲルがハイスループット薬剤スクリーニングのための3Dモデルの開発を可能にし、製薬およびバイオテクノロジー業界による採用を促進するという事実に起因しています。さらに、がん、心血管疾患、糖尿病などの慢性疾患を研究するための高度なin vitroモデルに対するニーズの高まりが、生物医学研究におけるハイドロゲルの需要を促進しています。世界保健機関（WHO）が発表した2023年の調査では、慢性疾患が原因で毎年約4,100万人が死亡していることが明らかになりました。組織の微小環境をシミュレートするためにハイドロゲルを組み込むことが多い臓器オンチップ技術の採用が増加し、市場をさらに促進しています。しかし、硬さ、多孔性、分解速度などのハイドロゲル特性を特定の用途に合わせて調整するためには、技術的な専門知識と時間が必要であり、これが市場成長の障壁となっています。さらに、マイクロキャリアを用いた細胞培養やスフェロイドのような足場を用いない方法のような代替の3D培養法が利用可能であることも、市場成長の課題となり得ます。それとは逆に、調整可能な特性や刺激応答性挙動を持つスマートハイドロゲルなど、ハイドロゲル製剤の技術革新は、その機能性と応用を拡大しています。組織工学と再生医療における研究と臨床の取り組みの増加は、機能的組織構築物を作成するための主要な生体材料として機能するハイドロゲルの需要を押し上げています。このような発展は、予測期間中の世界市場拡大に有利な機会を提供すると期待されています。

細胞培養ハイドロゲル市場は、ハイドロゲルタイプ、用途、エンドユーザー、地域に区分されます。ハイドロゲルタイプ別では、市場は天然ハイドロゲル、合成ハイドロゲル、ハイブリッドハイドロゲルに区分されます。用途別では、がん・幹細胞研究、組織工学・再生医療、創薬・毒性試験、その他に区分されます。エンドユーザー別では、製薬・バイオテクノロジー企業、CRO、研究機関、その他に区分されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他）、アジア太平洋（日本、中国、インド、オーストラリア、韓国、その他）、ラテンアメリカ・中東・アフリカ（ブラジル、南アフリカ、サウジアラビア、その他）に分けて分析しています。

主な調査結果

ハイドロゲルタイプ別では、2023年に合成ハイドロゲルセグメントがシェアで優位を占め、2024年～2035年に最も高いCAGRを記録すると予測されます。

用途別では、組織工学・再生医療セグメントが2023年に最大のシェアを獲得しましたが、予測期間中はがん・幹細胞研究セグメントが最も高いCAGRで成長すると予測されています。

エンドユーザー別では、製薬・バイオテクノロジー企業セグメントが2023年の主要セグメントでしたが、予測期間中はCROセグメントが最も高いCAGRを示すと予測されています。

地域別では、北米が2023年の世界の細胞培養ハイドロゲル市場の最大地域でしたが、予測期間中はアジア太平洋が最も高いCAGRを記録すると予測されています。

競合分析

利害関係者にとっての主なメリット

当レポートでは、2023年～2035年の細胞培養ハイドロゲル市場分析の市場セグメント、現在の動向、推定・分析、力学を定量的に分析し、細胞培養ハイドロゲル市場の有力な機会を特定します。

市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。

ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。

細胞培養ハイドロゲル市場のセグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。

各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。

市場企業のポジショニングはベンチマーキングを容易にし、市場企業の現在のポジションを明確に理解することができます。

本レポートには、地域別および世界の細胞培養ハイドロゲル市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なレポートカスタマイズ（追加費用とタイムラインに関しましては販売担当へご連絡ください）

  • 製品別/セグメント別の企業の市場シェア分析
  • 主な企業の新製品開発/製品マトリックス
  • クライアントの関心に応じた追加企業プロファイル
  • 企業プロファイルの拡張リスト
  • 過去の市場データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 影響要因
    • 主な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 創薬および毒性試験への応用
      • 慢性疾患と高齢者人口の増加
      • 3D細胞培養の需要増加
    • 抑制要因
      • 熟練労働力の不足
    • 機会
      • 新興市場における高い成長の可能性
      • バイオテクノロジーとライフサイエンスの進歩

第4章 細胞培養ハイドロゲル市場：ハイドロゲルタイプ別

  • 概要
  • 天然ハイドロゲル
  • 合成ハイドロゲル
  • ハイブリッドハイドロゲル

第5章 細胞培養ハイドロゲル市場：用途別

  • 概要
  • がん・幹細胞研究
  • 組織工学・再生医療
  • 創薬・毒性試験
  • その他

第6章 細胞培養ハイドロゲル市場：エンドユーザー別

  • 概要
  • 製薬・バイオテクノロジー企業
  • CRO
  • 研究機関
  • その他

第7章 細胞培養ハイドロゲル市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • オーストラリア
    • インド
    • 韓国
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Corning Incorporated
  • Merck KGaA
  • Humabiologics, Inc
  • BICO
  • TheWell Bioscience Inc.
  • CD Bioparticles
  • PELOBIOTECH GmbH
  • Cell Guidance Systems
  • UPM
  • Cellendes GmbH
目次
Product Code: A325248

The cell culture hydrogel market was valued at $400.0 million in 2023 and is estimated to reach $2,136.7 million by 2035, exhibiting a CAGR of 15.0% from 2024 to 2035.

Cell Culture Hydrogel Market - IMG1

Cell culture hydrogel is a three-dimensional, water-rich polymeric materials designed to mimic the extracellular matrix (ECM) environment for culturing cells in vitro. These hydrogels provide structural support, biochemical cues, and mechanical properties essential for maintaining cellular function, proliferation, and differentiation. They are commonly used in biomedical research, including tissue engineering, regenerative medicine, and drug discovery.

Increase in focus on stem cell therapies and research is a key factors that has fueled the demand for hydrogels, which support stem cell growth and differentiation by mimicking natural cellular environments. In addition, the transition from 2D to 3D cell cultures for drug screening, organoid development, and regenerative medicine has significantly increased the demand for hydrogels. Studies have shown that organoid cultures supported by synthetic hydrogels with tunable mechanical properties enhance reproducibility and mimic organ-like structures more accurately compared to traditional Matrigel scaffolds. Moreover, rising applications in drug discovery and development fuel the growth of the market. This is attributed to the fact that hydrogels enable the development of 3D models for high-throughput drug screening, enhancing their adoption by pharmaceutical and biotechnology industries. Furthermore, rise in need for advanced in vitro models to study chronic diseases like cancer, cardiovascular conditions, and diabetes is fueling the demand for hydrogels in biomedical research. A 2023 study published by the World Health Organization revealed that approximately 41 million individuals die each year due to chronic diseases. Rise in adoption of organ-on-a-chip technologies, which often incorporate hydrogels to simulate tissue microenvironments, further propels the market. However, requirement for tailoring hydrogel properties, such as stiffness, porosity, and degradation rate, to suit specific applications demands technical expertise and time, which acts as a barrier for the market growth. Moreover, availability of alternative 3D culture methods such as microcarrier-based cell cultures or scaffold-free methods like spheroids, can pose challenges to the market growth. On the contrary, innovations in hydrogel formulations, such as smart hydrogels with tunable properties and stimuli-responsive behavior, are expanding their functionality and applications. Rise in research and clinical efforts in tissue engineering and regenerative medicine are boosting the demand for hydrogels, which serve as key biomaterials for creating functional tissue constructs. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The cell culture hydrogel market is segmented into type of hydrogel, application, end user, and region. By type of hydrogel, the market is segmented into natural hydrogels, synthetic hydrogels, hybrid hydrogels. By application, the market is segmented into cancer and stem cell research, tissue engineering and regenerative medicine, drug discovery and toxicology testing, and others. By end user, the market is segregated into pharmaceutical and biotechnology companies, CROs, research institution, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Key Findings

Depending on type of hydrogel, the synthetic hydrogels segment dominated the share, in terms of share, in 2023, and is expected to register the highest CAGR from 2024 to 2035.

On the basis of application, the tissue engineering & regenerative medicine segment garnered the largest share in 2023; however, the cancer & stem cell research segment is expected to grow at the highest CAGR during the forecast period.

By end user, the pharmaceutical and biotechnology companies segment was the major shareholder in 2023; however, the CROs segment is anticipated to exhibit the highest CAGR during the forecast period.

Region wise, North America was the largest shareholder in the global cell culture hydrogel market in 2023; however, Asia-Pacific is anticipated to register the highest CAGR during the forecast period.

Competitive Analysis

The key players that operate in the global cell culture hydrogel market are Corning Incorporated, Merck KGaA, Humabiologics, Inc, Cell Guidance Systems, TheWell Bioscience Inc., CD Bioparticles, BICO, PELOBIOTECH GmbH, UPM, and Cellendes GmbH. These players have adopted expansion, agreement, partnership, and collaboration as their key strategies to strengthen their foothold in the global market

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell culture hydrogel market analysis from 2023 to 2035 to identify the prevailing cell culture hydrogel market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the cell culture hydrogel market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global cell culture hydrogel market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type of Hydrogel

  • Synthetic Hydrogels
  • Hybrid Hydrogels
  • Natural Hydrogels

By Application

  • Cancer and Stem Cell Research
  • Tissue Engineering and Regenerative Medicine
  • Drug Discovery and Toxicology Testing
  • Others

By End User

  • Research Institutions
  • Others
  • Pharmaceutical and Biotechnology Companies
  • CROs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Corning Incorporated
    • Merck KGaA
    • Humabiologics, Inc
    • UPM
    • PELOBIOTECH GmbH
    • CD Bioparticles
    • Cell Guidance Systems
    • BICO
    • TheWell Bioscience Inc.
    • Cellendes GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Applications in drug discovery and toxicology testing
      • 3.4.1.2. Rise in prevalence of chronic diseases and aging population
      • 3.4.1.3. Rise in demand for 3D cell culture
    • 3.4.2. Restraints
      • 3.4.2.1. Lack of a skilled workforce
    • 3.4.3. Opportunities
      • 3.4.3.1. High growth potential in emerging markets
      • 3.4.3.2. Advancements in biotechnology and life sciences

CHAPTER 4: CELL CULTURE HYDROGEL MARKET, BY TYPE OF HYDROGEL

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Natural Hydrogels
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Synthetic Hydrogels
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Hybrid Hydrogels
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CELL CULTURE HYDROGEL MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Cancer and Stem Cell Research
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Tissue Engineering and Regenerative Medicine
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Drug Discovery and Toxicology Testing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: CELL CULTURE HYDROGEL MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. CROs
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Research Institutions
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: CELL CULTURE HYDROGEL MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type of Hydrogel
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type of Hydrogel
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type of Hydrogel
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type of Hydrogel
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type of Hydrogel
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type of Hydrogel
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type of Hydrogel
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Corning Incorporated
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Merck KGaA
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Humabiologics, Inc
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Key strategic moves and developments
  • 9.4. BICO
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. TheWell Bioscience Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Key strategic moves and developments
  • 9.6. CD Bioparticles
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. PELOBIOTECH GmbH
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Cell Guidance Systems
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. UPM
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Cellendes GmbH
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio